Medicare Reform Focus Moving To House: Senate Markup Delayed
Executive Summary
The Medicare prescription drug benefit debate is shifting back to the House after the Senate Finance Committee's acknowledgement that it will not meet its goal of moving a bill before the August recess.
You may also be interested in...
House Medicare Rx Bill Could Be Ready For Floor Vote In October
The House Energy & Commerce and Ways & Means Committees plan to introduce a joint Medicare prescription drug benefit bill in late September, which could allow floor action in October.
House Medicare Rx Bill Could Be Ready For Floor Vote In October
The House Energy & Commerce and Ways & Means Committees plan to introduce a joint Medicare prescription drug benefit bill in late September, which could allow floor action in October.
DTC Restrictions Under Consideration For House Medicare Rx Bill
House Ways & Means Committee leadership is considering adding direct-to-consumer advertising restrictions to Medicare prescription drug benefit legislation.